<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01527292</url>
  </required_header>
  <id_info>
    <org_study_id>BCC-RAD-11-01</org_study_id>
    <nct_id>NCT01527292</nct_id>
  </id_info>
  <brief_title>Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis</brief_title>
  <official_title>Randomized Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>James Graham Brown Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine pain control rate (Percentage of patients in each
      arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months
      post-treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible Vertebral Metastatic Lesion/s-&gt; randomized-&gt; SRT versus SRT+ VAP Stereotactic
      Radiation Therapy(SRT): 16 Gy X 1 Evaluation: prior to treatment; 1 month, 2-4 months, 5-6
      months and 1 year post-treatment
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to enroll
  </why_stopped>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">September 2, 2015</completion_date>
  <primary_completion_date type="Actual">May 2, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Pain Scale (NRPS) Change in Patients</measure>
    <time_frame>For 6 months post treatment</time_frame>
    <description>To determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s)at 1 month, 2-4 months and 5-6 months post-treatment and to validate of the movement-related pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of Pain Estimate</measure>
    <time_frame>For 1 year post treatment</time_frame>
    <description>To estimate the relative quantitative reduction of pain from baseline in patients in each arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Estimate</measure>
    <time_frame>For 1 year post treatment</time_frame>
    <description>To estimate the quality of life using the Oswestry Disability Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility Rate Estimation</measure>
    <time_frame>For 1 year post treatment</time_frame>
    <description>To estimate the feasibility rate of the study procedure (the percentage of patients in overall and each arm that complete the treatment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity Rate Estimation</measure>
    <time_frame>For 1 year post treatment</time_frame>
    <description>To estimate the toxicities of the treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vertebra Measurement</measure>
    <time_frame>For 1 year post treatment</time_frame>
    <description>To measure the dimensions of the treated vertebra(e) at 1 year</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Vertebral Metastasis</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SRT with Vertebral Augmentation Procedure Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Stereotactic Radiation Therapy</intervention_name>
    <description>SRT only</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>Stereotactic Radiosurgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>SRT with Vertebral Augmentation Procedure</intervention_name>
    <description>SRT with VAP</description>
    <arm_group_label>Treatment Group</arm_group_label>
    <other_name>Stereotactic Radiosurgery with VAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years.

          2. ECOG performance status 0-1.

          3. Known histologically proven malignancy.

          4. Localized osteolytic spine metastases from T7 to L5 demonstrated by MRI, CT, PET or
             bone scan: a solitary spine metastasis; two separate spine levels; or up to 3 separate
             sites (each site may have a maximal involvement of 2 contiguous vertebral bodies with
             or without a paraspinal mass of no more than 5 cm).

          5. Negative serum pregnancy test within 2 weeks prior to registration for women of
             childbearing potential.

          6. Women of childbearing potential and male participants who are sexually active must
             agree to use a medically effective means of birth control.

          7. Numerical Rating Pain Scale (NRPS) and movement-related pain score(MRPS) within two
             (2) weeks prior to registration.

          8. The patient must have a score of ≥ 5 for at least one of the planned sites for SRT.

          9. Patients must provide study specific informed consent prior to study entry.

         10. Required Pre-treatment Evaluations: baseline Numerical Rating Pain Scale (NRPS),
             movement-related pain score, dose and frequency of all pain medications; QOL Measure
             using the Oswestry Disability Questionnaire, and EuroQOL(EQ-5D).

        Exclusion Criteria:

          1. Non-ambulatory patients.

          2. Frank spinal cord compression or epidural compression within 3 mm of the spinal cord.

          3. Osteoblastic vertebral metastasis.

          4. Prior radiation to the index spine.

          5. Patients with rapid neurologic decline.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiao Y Woo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>James Graham Brown Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>James Graham Brown Cancer Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <study_first_submitted>February 2, 2012</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <results_first_submitted>January 14, 2019</results_first_submitted>
  <results_first_submitted_qc>January 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2019</results_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Shiao Yuo Woo</investigator_full_name>
    <investigator_title>Chair-Radiation Oncology</investigator_title>
  </responsible_party>
  <keyword>Vertebral Metastasis</keyword>
  <keyword>pain control</keyword>
  <keyword>VAP</keyword>
  <keyword>SRT+VAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
        </group>
        <group group_id="P2">
          <title>Treatment Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Trial did not meet enrollment goal. Investigator did not analyze data due to low enrollment and early termination of trial</population>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
        </group>
        <group group_id="B2">
          <title>Treatment Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="61" lower_limit="56" upper_limit="64"/>
                    <measurement group_id="B3" value="61" lower_limit="56" upper_limit="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numerical Rating Pain Scale (NRPS) Change in Patients</title>
        <description>To determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s)at 1 month, 2-4 months and 5-6 months post-treatment and to validate of the movement-related pain score</description>
        <time_frame>For 6 months post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Numerical Rating Pain Scale (NRPS) Change in Patients</title>
          <description>To determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s)at 1 month, 2-4 months and 5-6 months post-treatment and to validate of the movement-related pain score</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reduction of Pain Estimate</title>
        <description>To estimate the relative quantitative reduction of pain from baseline in patients in each arm.</description>
        <time_frame>For 1 year post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Reduction of Pain Estimate</title>
          <description>To estimate the relative quantitative reduction of pain from baseline in patients in each arm.</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life Estimate</title>
        <description>To estimate the quality of life using the Oswestry Disability Questionnaire</description>
        <time_frame>For 1 year post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life Estimate</title>
          <description>To estimate the quality of life using the Oswestry Disability Questionnaire</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feasibility Rate Estimation</title>
        <description>To estimate the feasibility rate of the study procedure (the percentage of patients in overall and each arm that complete the treatment).</description>
        <time_frame>For 1 year post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Feasibility Rate Estimation</title>
          <description>To estimate the feasibility rate of the study procedure (the percentage of patients in overall and each arm that complete the treatment).</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Toxicity Rate Estimation</title>
        <description>To estimate the toxicities of the treatment</description>
        <time_frame>For 1 year post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Toxicity Rate Estimation</title>
          <description>To estimate the toxicities of the treatment</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vertebra Measurement</title>
        <description>To measure the dimensions of the treated vertebra(e) at 1 year</description>
        <time_frame>For 1 year post treatment</time_frame>
        <population>Data not analyzed due to low enrollment and early termination of study</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
          </group>
        </group_list>
        <measure>
          <title>Vertebra Measurement</title>
          <description>To measure the dimensions of the treated vertebra(e) at 1 year</description>
          <population>Data not analyzed due to low enrollment and early termination of study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
Stereotactic Radiation Therapy: SRT only</description>
        </group>
        <group group_id="E2">
          <title>Treatment Group</title>
          <description>Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure
SRT with Vertebral Augmentation Procedure: SRT with VAP</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Shiao Woo</name_or_title>
      <organization>University of Louisville, James Graham Brown Cancer Center</organization>
      <phone>502-561-2700</phone>
      <email>sywoo001@exchange.louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

